Allt inom Report
Nanexa publishes interim report for January-March 2024
NEX-22 clinical trial preparations ongoing and Novo Nordisk collaboration progressing well
Nanexa publishes annual report for 2023
Nanexa AB (publ) today announces that the annual report for 2023 has been published and is available on the company's website https://nanexa.com/en/financial-reports.
” A year that has brought us closer to commercialization and the expanding type 2 diabetes and obesity market.”
” In 2023,
